Adlon Therapeutics Social Media Community Guidelines

Social media is an important way for us to communicate with the patients and caregivers we serve. It gives us the opportunity to engage on platforms where patients and caregivers are already active and talking about important topics. We want to contribute to these important online communities and it is imperative that we do so in a responsible way. As a healthcare company, we operate within a rigorously regulated environment and we take the guidelines set forth by organizations, including the U.S. Food and Drug Administration, seriously. The guidelines set forth here are intended to outline how we engage on social media, and how we provide patients and their loved ones with information that may support them throughout their treatment journeys.

All of our social media channels are created and operated by Adlon Therapeutics L.P., which is a subsidiary of Purdue Pharma L.P. Our social media channels are intended for people in the United States, and as such, our content is in English only. We use our social media channels to provide resources for consideration and information on important health topics and to learn from the community. This is not a forum for medical advice and our content should never be considered a replacement for professional medical advice. We abide by a certain set of principles when we engage on social media. We will always be transparent about our affiliation and straightforward in how we present information.

Social media channels are often a place for discussion, but because of the regulated environment in which we operate, our ability to interact with you may be limited. In some social media channels, we have turned off commenting to prevent any content that does not follow our industry’s regulations. In other channels, comments are permitted but our ability to respond may be limited. Please do not use our social media channels to ask a medical question. You should speak directly with a healthcare professional if you have a medical question. If you have a question about one of our medicines, please reach out to us at 888-827-0618 and select option 1. Also, Adlon Therapeutics’ social media is not a place to report side effects from treatment. If you do experience a side effect from one of our medicines, you should speak to your healthcare provider and report the side effect to Adlon Therapeutics’ Drug Safety & Pharmacovigilance at 888-827-0618 and select option 2, or the FDA at 1-800-FDA-1088.

While we encourage you to interact with our posts through likes and shares, we do reserve the right to delete any comments or interactions deemed inappropriate. Examples of the types of posts that are not permitted are posts that:

  • Are disparaging in nature, use profanity, support any type of discriminatory behavior or have graphic language or content
  • Aim to sell commercial products or services
  • Spam the community
  • Ask medical questions or report adverse events*
  • Provide users with medical advice
  • Discuss off-label use of medications

Any accounts that we follow on social media or posts that we interact with do not constitute an endorsement and we hold no responsibility for the content on those pages.

Additionally, some linked third-party sites may contain content from sponsors, or sponsorships, paid by Adlon Therapeutics. As part of Adlon Therapeutics’ dedication to transparency and commitment to disclosure of paid relationships, paid sponsors will always clearly disclose this relationship on their websites and/or in their social media posts.

Thank you for engaging with our social media content and we look forward to being part of the community online.

* If you need immediate information about an Adlon product, or would like to speak with a Medical Information healthcare professional, please click here for contact information.

Bitnami